Schedule 13G ownership disclosure

REDHILL BIOPHARMA LTD

Security class unavailable · CUSIP: 757468103

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,906,124
Percent of class
6.1200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-000238
Form type
SC 13G
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 13, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub